ESCAPELLE

This brand name is authorized in Estonia, Hong Kong, Croatia, Lithuania, Malta, Poland, Romania, South Africa

Active ingredients

The drug ESCAPELLE contains one active pharmaceutical ingredient (API):

1 Levonorgestrel UNII 5W7SIA7YZW - LEVONORGESTREL

The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest. Read about Levonorgestrel

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ESCAPELLE Tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03AD01	Levonorgestrel	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AD Emergency contraceptives
Discover more medicines within G03AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1134100
Country: HK	Department of Health Drug Office	Identifier(s): 55811
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1021308, 1067940, 1074488, 1080184, 1087893, 1092804
Country: MT	Medicines Authority	Identifier(s): MA1031/00301
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100158979, 100260353, 100304381, 100324797, 100342720, 100399476, 100413740, 100432937
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W43332001
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/21.8.2/0021